** Shares of CurveBeam AI CVB.AX rise as much as 6.8% to A$0.094, their biggest intraday pct gain since March 31
** The medical equipment manufacturer says that it expects no material impact from tariffs announced by U.S. President Donald Trump
** Co highlights that it conducts majority of its manufacturing activities within the U.S.
** Shares of co fell 16.2% on Monday, in line with the markets sell-off seen globally amid recession fears
** Shares of CurveBeam down 31.1%, YTD
(Reporting by Nichiket Sunil in Bengaluru)
((Nichiket.Sunil@thomsonreuters.com;))
免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。